Mostrar el registro sencillo del ítem

dc.contributor.author
Mojica, Maria F.  
dc.contributor.author
Papp-Wallace, Krisztina M.  
dc.contributor.author
Taracila, Magdalena A.  
dc.contributor.author
Barnes, Melissa D.  
dc.contributor.author
Rutter, Joseph D.  
dc.contributor.author
Jacobs, Michael R.  
dc.contributor.author
LiPuma, John J.  
dc.contributor.author
Walsh, Thomas J.  
dc.contributor.author
Vila, Alejandro Jose  
dc.contributor.author
Bonomo, Robert A.  
dc.date.available
2018-12-05T18:46:16Z  
dc.date.issued
2017-09  
dc.identifier.citation
Mojica, Maria F.; Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Barnes, Melissa D.; Rutter, Joseph D.; et al.; Avibactam restores the susceptibility of clinical isolates of Stenotrophomonas maltophilia to aztreonam; American Society for Microbiology; Antimicrobial Agents and Chemotherapy; 61; 10; 9-2017; 1-5  
dc.identifier.issn
0066-4804  
dc.identifier.uri
http://hdl.handle.net/11336/65900  
dc.description.abstract
Stenotrophomonas maltophilia is an emerging opportunistic pathogen, classified by the World Health Organization as one of the leading multidrug-resistant organisms in hospital settings. The need to discover novel compounds and/or combination therapies for S. maltophilia is urgent. We demonstrate the in vitro efficacy of aztreonam-avibactam (ATM-AVI) against S. maltophilia and kinetically characterize the inhibition of the L2 β-lactamase by avibactam. ATM-AVI overcomes aztreonam resistance in selected clinical strains of S. maltophilia, addressing an unmet medical need.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
American Society for Microbiology  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Avibactam  
dc.subject
Aztreonam  
dc.subject
S. Maltophilia  
dc.subject.classification
Otras Ciencias Biológicas  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Avibactam restores the susceptibility of clinical isolates of Stenotrophomonas maltophilia to aztreonam  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-10-23T16:36:06Z  
dc.journal.volume
61  
dc.journal.number
10  
dc.journal.pagination
1-5  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Washington  
dc.description.fil
Fil: Mojica, Maria F.. Case Western Reserve University; Estados Unidos. Louis Stokes Veterans Affairs Medical Center; Estados Unidos  
dc.description.fil
Fil: Papp-Wallace, Krisztina M.. Case Western Reserve University; Estados Unidos. Louis Stokes Veterans Affairs Medical Center; Estados Unidos  
dc.description.fil
Fil: Taracila, Magdalena A.. Case Western Reserve University; Estados Unidos  
dc.description.fil
Fil: Barnes, Melissa D.. Louis Stokes Veterans Affairs Medical Center; Estados Unidos. Case Western Reserve University; Estados Unidos  
dc.description.fil
Fil: Rutter, Joseph D.. Louis Stokes Veterans Affairs Medical Center; Estados Unidos  
dc.description.fil
Fil: Jacobs, Michael R.. University Hospitals Cleveland Medical Center; Estados Unidos. Case Western Reserve University; Estados Unidos  
dc.description.fil
Fil: LiPuma, John J.. University of Michigan; Estados Unidos  
dc.description.fil
Fil: Walsh, Thomas J.. Weill Cornell Medical Center; Estados Unidos  
dc.description.fil
Fil: Vila, Alejandro Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Rosario. Instituto de Biología Molecular y Celular de Rosario. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas. Instituto de Biología Molecular y Celular de Rosario; Argentina  
dc.description.fil
Fil: Bonomo, Robert A.. Case Western Reserve University; Estados Unidos. Louis Stokes Veterans Affairs Medical Center; Estados Unidos. CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology; Estados Unidos  
dc.journal.title
Antimicrobial Agents and Chemotherapy  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://aac.asm.org/content/61/10/e00777-17.long  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1128/AAC.00777-17